Single-use Bioprocessing Probes and Sensors Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Single-use Bioprocessing Probes and Sensors Market size was valued at USD 3.1 billion in 2023 and is estimated to grow at 13.7% CAGR from 2024 to 2032. Single-use bioprocessing probes and sensors are disposable components used in biopharmaceutical manufacturing processes. These probes and sensors are designed to monitor and control various parameters such as pH, temperature, dissolved oxygen, conductivity, and biomass in bioreactors and other bioprocessing equipment.
The global demand for biopharmaceuticals has been steadily rising due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in healthcare infrastructure. Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell therapies, require precise and efficient bioprocessing technologies for manufacturing. Single-use bioprocessing probes and sensors play a crucial role in ensuring the quality, safety, and efficiency of biopharmaceutical production, thus experiencing increased demand alongside the growth of the biopharmaceutical industry.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Single-use Bioprocessing Probes and Sensors Market size in 2023: | USD 3.1 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2023 - 2032 CAGR: | 13.7 |
2023 Value Projection: | USD 10 Billion |
Historical Data for: | 2021 - 2023 |
No of Pages: | 106 |
Tables, Charts & Figures: | 215 |
Segments Covered: | Sensor Type, Workflow, End-use, and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Further, the biopharmaceutical industry is embracing single-use technologies due to their flexibility, speed, and reduced contamination risk compared to traditional stainless-steel equipment. These systems require less cleaning and validation, stimulating a trend towards their adoption, including single-use probes and sensors, to streamline manufacturing and expedite product launches.
Continuous innovation in bioprocessing technology has led to the development of advanced bioreactor systems such as single-use bioreactors and downstream processing techniques. These advancements often incorporate single-use technologies to improve operational efficiency, reduce contamination risks, and enhance flexibility in manufacturing processes. Single-use bioprocessing probes and sensors are integral components of these advanced bioprocessing systems, driving their adoption in the industry.
Based on sensor type, the single-use bioprocessing probes and sensors market is divided into pH sensors, oxygen sensors, pressure sensors, temperature sensors, conductivity sensors, flow meters & sensors, and other sensor types. The pH sensors segment of the market is forecasted to reach USD 2.2 billion by 2032, showcasing robust growth propelled by several key factors.
Based on workflow, the single-use bioprocessing probes and sensors market is bifurcated into upstream, and downstream. The upstream segment accounted for USD 2.4 billion in 2023.
Based on end-use, the single-use bioprocessing probes and sensors market is bifurcated into academic and research institutes, biopharma & pharmaceutical manufacturers, and contract manufacturing organizations (CMOs) & contract development and manufacturing organizations (CDMOs). The academic and research institutes segment accounted for USD 1.4 billion in 2023.
The single-use bioprocessing probes and sensors market in North America accounted for a significant revenue of 1.3 billion in 2023, and this trajectory is set to continue upwards.
The single-use bioprocessing probes and sensors industry in Germany is expected to experience significant and promising growth from 2024 to 2032.
UK is anticipated to witness robust growth in the global single-use bioprocessing probes and sensors market.
Japan single-use bioprocessing probes and sensors industry is anticipated to witness lucrative growth between 2024 – 2032.
The single-use bioprocessing probes and sensors market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
The single-use bioprocessing probes and sensors sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command significant influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
Some of the eminent market participants operating in the single-use bioprocessing probes and sensors industry include:
Market, By Sensor Type
Market, By Workflow
Market, By End-use
The above information is provided for the following regions and countries:
Broadley-James Corporation, Danaher Corporation, Dover Corporation, Eppendorf SE, Emerson Electric Co., Hamilton Company, Parker-Hannifin Corporation, PreSens Precision Sensing GmbH, Sartorius AG, Stobbe Pharma GmbH and Thermo Fisher Scientific Inc.
North America market accounted for USD 1.3 billion in revenue in 2023, attributed to the increasing demand for biopharmaceuticals and biologics in the region.
The pH sensors segment is forecasted to cross USD 2.2 billion by 2032, as pH levels directly impact the efficacy and yield of bioprocesses, influencing cell growth, product quality, and overall process efficiency.
The market size of single-use bioprocessing probes and sensors reached USD 3.1 billion in 2023 and is set to witness 13.7% CAGR from 2024 to 2032, owing to an aging population, increasing prevalence of chronic diseases, and advancements in healthcare infrastructure.